Accelerate Diagnostics Forecast and Stock Analysis
Technical AXDX stock analysis for March 25, 2019.
| Shorts | n/a |
| Cash | n/a |
| Loans | n/a |
| Beta | 3.18 |
| ROA | -56.84 |
Accelerate Diagnostics gained 2.16% in the last trading day, rising from $19.89 to $20.32 The price has been going up and down for this period, and there has been a 0.05% gain for the last 2 weeks. Volume fell in the last day by -90 187 shares, and in total, 133 242 shares bought and sold for approximately $2.71 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
Close price at the end of the last trading day (Monday, 25th Mar 2019) of the AXDX stock was $20.32. This is 2.16% more than the trading day before Friday, 22nd Mar 2019.
During day the stock fluctuated 4.00% from a day low at $19.58 to a day high of $20.36.
30 day high of the AXDX stock price was $22.42 and low was $19.19.
90 day high was $22.42 and low was $10.30.
52 week high for the Accelerate Diagnostics - $25.35 and low - $10.23.
Trend
Accelerate Diagnostics lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $20.03 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 53.03% during the next 3 months and, with 90% probability hold a price between $30.66 and $39.66 at the end of this period.
Signals
Only positive signals in the chart today. Accelerate Diagnostics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $20.06 and $20.19. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday March 22, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.
Access today's Top 5 Golden Star Companies
Relative Strength Index (RSI)
RSI14 is 40 and the stock is currently not being overbought or oversold
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at $18.93 and $17.41.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Accelerate Diagnostics finds support just below today's level at $18.93. If this is broken, then the next support from accumulated volume will be at $17.41 and $16.56.
Risk
This stock is usually traded at good volume, and with minor daily changes the risk is considered to be low. During the last day, the stock moved $0.78 (4.00%) between high and low. For the last week, the stock has had a daily average volatility of 4.91%.
Our recommended stoploss: $19.26 (-5.24%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
Overall risk:
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. We have upgraded our recommendation for this stock since last evaluation from a Strong Sell Candidate to a Buy Candidate.
